Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Individualizing Periods of Commercial Exclusivity to Control Pricing for Drugs and Biologics

: Blase, Callie M.; Rouault, Brandon K.; Zoller, Maia B.; Luff, Joshua V.; Lerch, Emma J.; Lauterbachq, Brynn N.; Brown, Mark A.; Storsberg, Joachim; Schmidt, Christian

Volltext (PDF; )

American Journal of Immunology 15 (2019), S.19-21
ISSN: 1553-619X (print)
ISSN: 1558-3775 (online)
Zeitschriftenaufsatz, Elektronische Publikation
Fraunhofer IAP ()

The pricing for immunologic agents and antibody-based therapeutics has increased precipitously in recent years. Among the key contributors to price hikes is the static practice of granting commercial exclusivity to innovator drugs and biologics. Herein, we present a mechanism for individualizing periods of commercial exclusivity to control pricing for drugs and biologics.